The NIHR Manchester BRC, in collaboration with the NIHR Manchester Clinical Research Facility (CRF) and supported by Corridor Manchester and Health Innovation Manchester is investing in the next generation of NHS researchers and want you to be part of it!
Researchers from the Manchester BRC are part of a UK-wide effort to drive the development of new, targeted treatments for children and young people with juvenile idiopathic arthritis (JIA) and its associated eye-inflammation condition, uveitis.
At the start of the year a panel of international experts from academia and industry visited Manchester for the first annual strategy workshop.
The Public Programmes team at Manchester University NHS Foundation Trust - who lead the involvement and engagement work for the NIHR Manchester Biomedical Research Centre and Clinical Research Facility - has been selected as one of ten organisations in the UK to become a test-bed for this work.
New research from The University of Manchester in collaboration with researchers at the University of East Anglia shows improved long-term outcomes for patients diagnosed with early inflammatory arthritis, when comparing to the previous 10 year period.
Over 150 delegates gathered in Manchester last week to hear about the work of the four northern NIHR Biomedical Research Centres (BRCs).
Recently published results from a LUPUS UK survey have revealed that lupus patients in the UK experience an average delay of 6.4 years between developing initial symptoms and reaching a diagnosis.
What is ‘trustworthy’ research, and how do you generate and communicate it?